2023
DOI: 10.3390/life13061369
|View full text |Cite
|
Sign up to set email alerts
|

Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study

Monika Słowińska,
Iwona Czarnecka,
Robert Czarnecki
et al.

Abstract: Background: Although the role of melanoma risk factors is well documented, their correlation with patients’ age is less frequently analyzed. Method: The analysis was performed among 189 melanoma patients in different age groups, including <30 years, 31–60 years, and >60 years, to investigate the risk factors, topography, and coexistence of morphological features of 209 melanomas (dermoscopic and histopathological). Results: Among the youngest age group, no correlation with the presence of estimated risk … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Recently, there has been a consistent escalation in the global occurrence of MM, imposing a huge economic burden on society [ 17 , 18 ]. Early surgical excision is the primary treatment approach for non-metastatic cutaneous malignant melanoma, yielding favorable survival outcomes [ 19 , 20 ]. In recent years, despite the significant shift in treatment approach for advanced melanoma through the use of targeted therapy and immunotherapy, the risk of mortality in metastatic melanoma remains very high [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, there has been a consistent escalation in the global occurrence of MM, imposing a huge economic burden on society [ 17 , 18 ]. Early surgical excision is the primary treatment approach for non-metastatic cutaneous malignant melanoma, yielding favorable survival outcomes [ 19 , 20 ]. In recent years, despite the significant shift in treatment approach for advanced melanoma through the use of targeted therapy and immunotherapy, the risk of mortality in metastatic melanoma remains very high [ 21 ].…”
Section: Discussionmentioning
confidence: 99%